Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
16,409,744
-
Share change
-
-220,781
-
Total reported value
-
$269,579,465
-
Price per share
-
$16.43
-
Number of holders
-
45
-
Value change
-
-$3,736,848
-
Number of buys
-
27
-
Number of sells
-
13
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q4 2017
As of 31 Dec 2017,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,409,744 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Rock Springs Capital Management LP, ProQuest Associates IV LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., FIL Ltd, JPMORGAN CHASE & CO, Cormorant Asset Management, LLC, and FMR LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.